Evidence map›Paper›PMID 38089865›Full record

ArticleFrontiers in medicine2023

Case Report: A rare case of multicentric angiosarcomas of bone mimicking multiple myeloma on

Wenpeng Huang, Xiaoyan Xiao, Yongbai Zhang, Yushuo Peng, Lele Song, Liming Li, Jianbo Gao, Lei Kang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Xiaoyan XiaoDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Yongbai ZhangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Yushuo PengDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Lele SongDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Liming LiDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Jianbo GaoDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
First Affiliated Hospital of Zhengzhou University · CNPeking University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Angiosarcoma, a rare endothelial-origin tumor, can develop throughout the body, with the head and neck skin being the most commonly affected areas. It can also originate in other sites such as the breast, iliac artery, and visceral organs including the liver, spleen, and kidneys. Angiosarcoma of the bone is remarkably rare, presenting as either unifocal or multifocal bone lesions and often leading to a grim prognosis. Diagnosing bone angiosarcoma poses a significant challenge. Case report: A 57-year-old woman presented with a 10-day history of dizziness and headaches. Cranial CT scan revealed bone destruction of the parietal bone, accompanied by soft tissue lesions, protruding into the epidural space. MRI examination demonstrated lesions with slightly elevated signal intensity on T2FLAIR, showing moderate enhancement. Furthermore, multiple foci were observed within the T Conclusion: Angiosarcoma of bone on FDG PET/CT scans is characterized by abnormal FDG uptake along with osteolytic destruction. This case highlights that angiosarcoma of bone can manifest as multicentric FDG uptake, resembling the pattern seen in multiple myeloma. FDG PET/CT can be a useful tool for staging this rare malignant tumor, offering the potential to guide biopsy procedures toward the most metabolically active site. And it should be considered in the differential diagnosis of multiple osteolytic lesions, including metastatic carcinoma, multiple myeloma, and lymphoma of bone.

Indexed as

18F-FDG PET/CTangiosarcomabonecase reportcomputed tomographymagnetic resonance imaging

Identifiers

PMID38089865
PMCPMC10715254
OpenAlexW4389098301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.